-
1
-
-
0032814384
-
Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA
-
Arase Y., Ikeda K., Chayama K., Murashima N., Tsubota A., Suzuki Y., Saitoh S., Kobayashi M., Kobayashi M., Kobayashi M., and Kumada H. Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA. Intern. Med. 38 (1999) 461-466
-
(1999)
Intern. Med.
, vol.38
, pp. 461-466
-
-
Arase, Y.1
Ikeda, K.2
Chayama, K.3
Murashima, N.4
Tsubota, A.5
Suzuki, Y.6
Saitoh, S.7
Kobayashi, M.8
Kobayashi, M.9
Kobayashi, M.10
Kumada, H.11
-
2
-
-
0033653568
-
Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment
-
Berg T., Mas Marques A., Hohne M., Wiedenmann B., Hopf U., and Schreier E. Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment. Hepatology 32 (2000) 1386-1395
-
(2000)
Hepatology
, vol.32
, pp. 1386-1395
-
-
Berg, T.1
Mas Marques, A.2
Hohne, M.3
Wiedenmann, B.4
Hopf, U.5
Schreier, E.6
-
3
-
-
0031050892
-
Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection
-
Chayama K., Tsubota A., Kobayashi M., Okamoto K., Hashimoto M., Miyano Y., Koike H., Kobayashi M., Koida I., Arase Y., Saitoh S., Suzuki Y., Murashima N., Ikeda K., and Kumada H. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25 (1997) 745-749
-
(1997)
Hepatology
, vol.25
, pp. 745-749
-
-
Chayama, K.1
Tsubota, A.2
Kobayashi, M.3
Okamoto, K.4
Hashimoto, M.5
Miyano, Y.6
Koike, H.7
Kobayashi, M.8
Koida, I.9
Arase, Y.10
Saitoh, S.11
Suzuki, Y.12
Murashima, N.13
Ikeda, K.14
Kumada, H.15
-
4
-
-
34250621773
-
Hepatitis C virus: virology, diagnosis and management of antiviral therapy
-
Chevaliez S., and Pawlotsky J.M. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J. Gastroenterol. 13 (2007) 2461-2466
-
(2007)
World J. Gastroenterol.
, vol.13
, pp. 2461-2466
-
-
Chevaliez, S.1
Pawlotsky, J.M.2
-
5
-
-
0032791543
-
Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus
-
Chung R.T., Monto A., Dienstag J.L., and Kaplan L.M. Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus. J. Med. Virol. 58 (1999) 353-358
-
(1999)
J. Med. Virol.
, vol.58
, pp. 353-358
-
-
Chung, R.T.1
Monto, A.2
Dienstag, J.L.3
Kaplan, L.M.4
-
6
-
-
30644478836
-
Viruses as quasispecies: biological implications
-
Domingo E., Martin V., Perales C., Grande-Perez A., Garcia-Arriaza J., and Arias A. Viruses as quasispecies: biological implications. Curr. Top. Microbiol. Immunol. 299 (2006) 51-82
-
(2006)
Curr. Top. Microbiol. Immunol.
, vol.299
, pp. 51-82
-
-
Domingo, E.1
Martin, V.2
Perales, C.3
Grande-Perez, A.4
Garcia-Arriaza, J.5
Arias, A.6
-
7
-
-
0031836249
-
Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity
-
Duverlie G., Khorsi H., Castelain S., Jaillon O., Izopet J., Lunel F., Eb F., Penin F., and Wychowski C. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. J. Gen. Virol. 79 Pt 6 (1998) 1373-1381
-
(1998)
J. Gen. Virol.
, vol.79
, Issue.PART 6
, pp. 1373-1381
-
-
Duverlie, G.1
Khorsi, H.2
Castelain, S.3
Jaillon, O.4
Izopet, J.5
Lunel, F.6
Eb, F.7
Penin, F.8
Wychowski, C.9
-
8
-
-
34247395820
-
Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera
-
El-Shamy A., Sasayama M., Nagano-Fujii M., Sasase N., Imoto S., Kim S.R., and Hotta H. Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera. Microbiol. Immunol. 51 (2007) 471-482
-
(2007)
Microbiol. Immunol.
, vol.51
, pp. 471-482
-
-
El-Shamy, A.1
Sasayama, M.2
Nagano-Fujii, M.3
Sasase, N.4
Imoto, S.5
Kim, S.R.6
Hotta, H.7
-
9
-
-
0029161576
-
Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region
-
Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., and Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Invest. 96 (1995) 224-230
-
(1995)
J. Clin. Invest.
, vol.96
, pp. 224-230
-
-
Enomoto, N.1
Sakuma, I.2
Asahina, Y.3
Kurosaki, M.4
Murakami, T.5
Yamamoto, C.6
Izumi, N.7
Marumo, F.8
Sato, C.9
-
10
-
-
0031978181
-
Base-calling of automated sequencer traces using phred. II. Error probabilities
-
Ewing B., and Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 8 (1998) 186-194
-
(1998)
Genome Res.
, vol.8
, pp. 186-194
-
-
Ewing, B.1
Green, P.2
-
11
-
-
0031955518
-
Base-calling of automated sequencer traces using phred. I. Accuracy assessment
-
Ewing B., Hillier L., Wendl M.C., and Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 8 (1998) 175-185
-
(1998)
Genome Res.
, vol.8
, pp. 175-185
-
-
Ewing, B.1
Hillier, L.2
Wendl, M.C.3
Green, P.4
-
12
-
-
20444371955
-
Nonstructural 5A gene variability of hepatitis C virus (HCV) during a 10-year follow up
-
Fan W., Zhu W., Wei L., Wang Q., Yin L., Du S., and Zhuang H. Nonstructural 5A gene variability of hepatitis C virus (HCV) during a 10-year follow up. J. Gastroenterol. 40 (2005) 43-51
-
(2005)
J. Gastroenterol.
, vol.40
, pp. 43-51
-
-
Fan, W.1
Zhu, W.2
Wei, L.3
Wang, Q.4
Yin, L.5
Du, S.6
Zhuang, H.7
-
13
-
-
0034646996
-
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
-
Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., Strazzera A., Chien D.Y., Munoz S.J., Balestrieri A., Purcell R.H., and Alter H.J. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288 (2000) 339-344
-
(2000)
Science
, vol.288
, pp. 339-344
-
-
Farci, P.1
Shimoda, A.2
Coiana, A.3
Diaz, G.4
Peddis, G.5
Melpolder, J.C.6
Strazzera, A.7
Chien, D.Y.8
Munoz, S.J.9
Balestrieri, A.10
Purcell, R.H.11
Alter, H.J.12
-
14
-
-
0037022678
-
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome
-
Farci P., Strazzera R., Alter H.J., Farci S., Degioannis D., Coiana A., Peddis G., Usai F., Serra G., Chessa L., Diaz G., Balestrieri A., and Purcell R.H. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3081-3086
-
(2002)
Proc. Natl. Acad. Sci. U.S.A.
, vol.99
, pp. 3081-3086
-
-
Farci, P.1
Strazzera, R.2
Alter, H.J.3
Farci, S.4
Degioannis, D.5
Coiana, A.6
Peddis, G.7
Usai, F.8
Serra, G.9
Chessa, L.10
Diaz, G.11
Balestrieri, A.12
Purcell, R.H.13
-
15
-
-
0033224562
-
The molecular biology of hepatitis C virus. Genotypes and quasispecies
-
vii
-
Forns X., and Bukh J. The molecular biology of hepatitis C virus. Genotypes and quasispecies. Clin. Liver Dis. 3 (1999) 693-716 vii
-
(1999)
Clin. Liver Dis.
, vol.3
, pp. 693-716
-
-
Forns, X.1
Bukh, J.2
-
16
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales Jr. F.L., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., and Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347 (2002) 975-982
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Goncales Jr., F.L.6
Haussinger, D.7
Diago, M.8
Carosi, G.9
Dhumeaux, D.10
Craxi, A.11
Lin, A.12
Hoffman, J.13
Yu, J.14
-
17
-
-
0343924357
-
Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
-
Gale Jr. M.J., Korth M.J., Tang N.M., Tan S.L., Hopkins D.A., Dever T.E., Polyak S.J., Gretch D.R., and Katze M.G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230 (1997) 217-227
-
(1997)
Virology
, vol.230
, pp. 217-227
-
-
Gale Jr., M.J.1
Korth, M.J.2
Tang, N.M.3
Tan, S.L.4
Hopkins, D.A.5
Dever, T.E.6
Polyak, S.J.7
Gretch, D.R.8
Katze, M.G.9
-
18
-
-
10744225097
-
Global burden of disease (GBD) for hepatitis C
-
GBD
-
GBD, 2004. Global burden of disease (GBD) for hepatitis C. J. Clin. Pharmacol. 44, 20-29.
-
(2004)
J. Clin. Pharmacol
, vol.44
, pp. 20-29
-
-
-
19
-
-
0031955116
-
Consed: a graphical tool for sequence finishing
-
Gordon D., Abajian C., and Green P. Consed: a graphical tool for sequence finishing. Genome Res. 8 (1998) 195-202
-
(1998)
Genome Res.
, vol.8
, pp. 195-202
-
-
Gordon, D.1
Abajian, C.2
Green, P.3
-
20
-
-
1542378867
-
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
-
Hadziyannis S.J., Sette Jr. H., Morgan T.R., Balan V., Diago M., Marcellin P., Ramadori G., Bodenheimer Jr. H., Bernstein D., Rizzetto M., Zeuzem S., Pockros P.J., Lin A., and Ackrill A.M. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 140 (2004) 346-355
-
(2004)
Ann. Intern. Med.
, vol.140
, pp. 346-355
-
-
Hadziyannis, S.J.1
Sette Jr., H.2
Morgan, T.R.3
Balan, V.4
Diago, M.5
Marcellin, P.6
Ramadori, G.7
Bodenheimer Jr., H.8
Bernstein, D.9
Rizzetto, M.10
Zeuzem, S.11
Pockros, P.J.12
Lin, A.13
Ackrill, A.M.14
-
21
-
-
0002051540
-
BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT
-
Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series, vol. 41 (1999) 95-98
-
(1999)
Nucleic Acids Symposium Series, vol. 41
, pp. 95-98
-
-
Hall, T.A.1
-
22
-
-
11844280823
-
Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy
-
Hofmann W.P., Zeuzem S., and Sarrazin C. Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy. J. Clin. Virol. 32 (2005) 86-91
-
(2005)
J. Clin. Virol.
, vol.32
, pp. 86-91
-
-
Hofmann, W.P.1
Zeuzem, S.2
Sarrazin, C.3
-
23
-
-
0030571476
-
Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A
-
Ide Y., Zhang L., Chen M., Inchauspe G., Bahl C., Sasaguri Y., and Padmanabhan R. Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182 (1996) 203-211
-
(1996)
Gene
, vol.182
, pp. 203-211
-
-
Ide, Y.1
Zhang, L.2
Chen, M.3
Inchauspe, G.4
Bahl, C.5
Sasaguri, Y.6
Padmanabhan, R.7
-
24
-
-
0025787597
-
Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates
-
Inchauspe G., Zebedee S., Lee D.H., Sugitani M., Nasoff M., and Prince A.M. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10292-10296
-
(1991)
Proc. Natl. Acad. Sci. U.S.A.
, vol.88
, pp. 10292-10296
-
-
Inchauspe, G.1
Zebedee, S.2
Lee, D.H.3
Sugitani, M.4
Nasoff, M.5
Prince, A.M.6
-
25
-
-
33646180828
-
Mutations within protein kinase R-binding domain of NS5A protein of hepatitis C virus (HCV) and specificity of HCV antibodies in pretreatment sera of HCV-chronically infected patients and their effect on the result of treatment
-
Kmieciak D., Kruszyna L., Migdalski P., Lacinski M., Juszczyk J., and Trzeciak W.H. Mutations within protein kinase R-binding domain of NS5A protein of hepatitis C virus (HCV) and specificity of HCV antibodies in pretreatment sera of HCV-chronically infected patients and their effect on the result of treatment. Jpn. J. Infect. Dis. 59 (2006) 92-99
-
(2006)
Jpn. J. Infect. Dis.
, vol.59
, pp. 92-99
-
-
Kmieciak, D.1
Kruszyna, L.2
Migdalski, P.3
Lacinski, M.4
Juszczyk, J.5
Trzeciak, W.H.6
-
27
-
-
34250617883
-
Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy
-
Le Guillou-Guillemette H., Vallet S., Gaudy-Graffin C., Payan C., Pivert A., Goudeau A., and Lunel-Fabiani F. Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy. World J. Gastroenterol. 13 (2007) 2416-2426
-
(2007)
World J. Gastroenterol.
, vol.13
, pp. 2416-2426
-
-
Le Guillou-Guillemette, H.1
Vallet, S.2
Gaudy-Graffin, C.3
Payan, C.4
Pivert, A.5
Goudeau, A.6
Lunel-Fabiani, F.7
-
28
-
-
4544336360
-
Hepatitis C virus NS5A: tales of a promiscuous protein
-
Macdonald A., and Harris M. Hepatitis C virus NS5A: tales of a promiscuous protein. J. Gen. Virol. 85 (2004) 2485-2502
-
(2004)
J. Gen. Virol.
, vol.85
, pp. 2485-2502
-
-
Macdonald, A.1
Harris, M.2
-
29
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
-
Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M., and Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffman, M.5
Reindollar, R.6
Goodman, Z.D.7
Koury, K.8
Ling, M.9
Albrecht, J.K.10
-
30
-
-
0026538287
-
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution
-
Martell M., Esteban J.I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., and Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66 (1992) 3225-3229
-
(1992)
J. Virol.
, vol.66
, pp. 3225-3229
-
-
Martell, M.1
Esteban, J.I.2
Quer, J.3
Genesca, J.4
Weiner, A.5
Esteban, R.6
Guardia, J.7
Gomez, J.8
-
31
-
-
68949118090
-
Library s routines for pattern recognition in quasispecies
-
in press
-
Marucci, E.A., Zafalon, G.F.D., Jardim, A.C.G., Yamasaki, L.H.T., Bittar, C., Rahal, P., Machado, J.M. Library s routines for pattern recognition in quasispecies. Genet. Mol. Res., in press.
-
Genet. Mol. Res
-
-
Marucci, E.A.1
Zafalon, G.F.D.2
Jardim, A.C.G.3
Yamasaki, L.H.T.4
Bittar, C.5
Rahal, P.6
Machado, J.M.7
-
32
-
-
0036321652
-
The application of molecular phylogenetics to the analysis of viral genome diversity and evolution
-
McCormack G.P., and Clewley J.P. The application of molecular phylogenetics to the analysis of viral genome diversity and evolution. Rev. Med. Virol. 12 (2002) 221-238
-
(2002)
Rev. Med. Virol.
, vol.12
, pp. 221-238
-
-
McCormack, G.P.1
Clewley, J.P.2
-
33
-
-
33845484433
-
Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy
-
Medeiros-Filho J.E., Mello I.M.V.G.C., Pinho J.R.R., Neumann A.U., Malta F.F., da Silva L.C., and Carrilho F.J. Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy. World J. Gastroenterol. 12 (2006) 7271-7277
-
(2006)
World J. Gastroenterol.
, vol.12
, pp. 7271-7277
-
-
Medeiros-Filho, J.E.1
Mello, I.M.V.G.C.2
Pinho, J.R.R.3
Neumann, A.U.4
Malta, F.F.5
da Silva, L.C.6
Carrilho, F.J.7
-
34
-
-
33845423064
-
A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1B
-
Murayama M., Katano Y., Nakano I., Ishigami M., Hayashi K., Honda T., Hirooka Y., Itoh A., and Goto H. A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1B. J. Med. Virol. 79 (2007) 35-40
-
(2007)
J. Med. Virol.
, vol.79
, pp. 35-40
-
-
Murayama, M.1
Katano, Y.2
Nakano, I.3
Ishigami, M.4
Hayashi, K.5
Honda, T.6
Hirooka, Y.7
Itoh, A.8
Goto, H.9
-
35
-
-
0036277038
-
Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection
-
Murphy M.D., Rosen H.R., Marousek G.I., and Chou S. Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection. Dig. Dis. Sci. 47 (2002) 1195-1205
-
(2002)
Dig. Dis. Sci.
, vol.47
, pp. 1195-1205
-
-
Murphy, M.D.1
Rosen, H.R.2
Marousek, G.I.3
Chou, S.4
-
36
-
-
0033002009
-
Why is the interferon sensitivity-determining region (ISDR) system useful in Japan?
-
Nakano I., Fukuda Y., Katano Y., Nakano S., Kumada T., and Hayakawa T. Why is the interferon sensitivity-determining region (ISDR) system useful in Japan?. J. Hepatol. 30 (1999) 1014-1022
-
(1999)
J. Hepatol.
, vol.30
, pp. 1014-1022
-
-
Nakano, I.1
Fukuda, Y.2
Katano, Y.3
Nakano, S.4
Kumada, T.5
Hayakawa, T.6
-
37
-
-
0033807806
-
Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy
-
Nousbaum J., Polyak S.J., Ray S.C., Sullivan D.G., Larson A.M., Carithers Jr. R.L., and Gretch D.R. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. J. Virol. 74 (2000) 9028-9038
-
(2000)
J. Virol.
, vol.74
, pp. 9028-9038
-
-
Nousbaum, J.1
Polyak, S.J.2
Ray, S.C.3
Sullivan, D.G.4
Larson, A.M.5
Carithers Jr., R.L.6
Gretch, D.R.7
-
38
-
-
4344570256
-
Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences
-
Pascu M., Martus P., Hohne M., Wiedenmann B., Hopf U., Schreier E., and Berg T. Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences. Gut 53 (2004) 1345-1351
-
(2004)
Gut
, vol.53
, pp. 1345-1351
-
-
Pascu, M.1
Martus, P.2
Hohne, M.3
Wiedenmann, B.4
Hopf, U.5
Schreier, E.6
Berg, T.7
-
39
-
-
0037301154
-
Hepatitis C virus genetic variability: pathogenic and clinical implications
-
Pawlotsky J.M. Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin. Liver Dis. 7 (2003) 45-66
-
(2003)
Clin. Liver Dis.
, vol.7
, pp. 45-66
-
-
Pawlotsky, J.M.1
-
40
-
-
0037784027
-
Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C
-
Pawlotsky J.M. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res. 59 (2003) 1-11
-
(2003)
Antiviral Res.
, vol.59
, pp. 1-11
-
-
Pawlotsky, J.M.1
-
41
-
-
14644402363
-
Current and future concepts in hepatitis C therapy
-
Pawlotsky J.M. Current and future concepts in hepatitis C therapy. Semin. Liver Dis. 25 (2005) 72-83
-
(2005)
Semin. Liver Dis.
, vol.25
, pp. 72-83
-
-
Pawlotsky, J.M.1
-
42
-
-
0032885602
-
The non-structural 5A protein of hepatitis C virus
-
Pawlotsky J.M., and Germanidis G. The non-structural 5A protein of hepatitis C virus. J. Viral Hepat. 6 (1999) 343-356
-
(1999)
J. Viral Hepat.
, vol.6
, pp. 343-356
-
-
Pawlotsky, J.M.1
Germanidis, G.2
-
43
-
-
0031923838
-
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations
-
Pawlotsky J.M., Germanidis G., Neumann A.U., Pellerin M., Frainais P.O., and Dhumeaux D. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J. Virol. 72 (1998) 2795-2805
-
(1998)
J. Virol.
, vol.72
, pp. 2795-2805
-
-
Pawlotsky, J.M.1
Germanidis, G.2
Neumann, A.U.3
Pellerin, M.4
Frainais, P.O.5
Dhumeaux, D.6
-
44
-
-
16544372861
-
Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions
-
Pellerin M., Lopez-Aguirre Y., Penin F., Dhumeaux D., and Pawlotsky J.M. Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions. J. Virol. 78 (2004) 4617-4627
-
(2004)
J. Virol.
, vol.78
, pp. 4617-4627
-
-
Pellerin, M.1
Lopez-Aguirre, Y.2
Penin, F.3
Dhumeaux, D.4
Pawlotsky, J.M.5
-
45
-
-
0033837013
-
The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon
-
Polyak S.J., Nousbaum J.B., Larson A.M., Cotler S., Carithers Jr. R.L., and Gretch D.R. The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon. J. Infect. Dis. 182 (2000) 397-404
-
(2000)
J. Infect. Dis.
, vol.182
, pp. 397-404
-
-
Polyak, S.J.1
Nousbaum, J.B.2
Larson, A.M.3
Cotler, S.4
Carithers Jr., R.L.5
Gretch, D.R.6
-
46
-
-
0031773680
-
MODELTEST: testing the model of DNA substitution
-
Posada D., and Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 14 (1998) 817-818
-
(1998)
Bioinformatics
, vol.14
, pp. 817-818
-
-
Posada, D.1
Crandall, K.A.2
-
47
-
-
0033965331
-
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?
-
The ALGOVIRC Project Group
-
Poynard T., McHutchison J., Goodman Z., Ling M.H., Albrecht J., and The ALGOVIRC Project Group. Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?. Hepatology 31 (2000) 211-218
-
(2000)
Hepatology
, vol.31
, pp. 211-218
-
-
Poynard, T.1
McHutchison, J.2
Goodman, Z.3
Ling, M.H.4
Albrecht, J.5
-
48
-
-
16844363814
-
Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C
-
Puig-Basagoiti F., Forns X., Furcic I., Ampurdanes S., Gimenez-Barcons M., Franco S., Sanchez-Tapias J.M., and Saiz J.C. Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C. J. Gen. Virol. 86 (2005) 1067-1075
-
(2005)
J. Gen. Virol.
, vol.86
, pp. 1067-1075
-
-
Puig-Basagoiti, F.1
Forns, X.2
Furcic, I.3
Ampurdanes, S.4
Gimenez-Barcons, M.5
Franco, S.6
Sanchez-Tapias, J.M.7
Saiz, J.C.8
-
49
-
-
0347513220
-
DnaSP, DNA polymorphism analyses by the coalescent and other methods
-
Rozas J., Sanchez-DelBarrio J.C., Messeguer X., and Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19 (2003) 2496-2497
-
(2003)
Bioinformatics
, vol.19
, pp. 2496-2497
-
-
Rozas, J.1
Sanchez-DelBarrio, J.C.2
Messeguer, X.3
Rozas, R.4
-
50
-
-
33745832698
-
Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C
-
Salmeron J., De Rueda P.M., Ruiz-Extremera A., Casado J., Huertas C., Bernal Mdel C., Rodriguez L., and Palacios A. Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C. Dig. Dis. Sci. 51 (2006) 960-967
-
(2006)
Dig. Dis. Sci.
, vol.51
, pp. 960-967
-
-
Salmeron, J.1
De Rueda, P.M.2
Ruiz-Extremera, A.3
Casado, J.4
Huertas, C.5
Bernal Mdel, C.6
Rodriguez, L.7
Palacios, A.8
-
51
-
-
0034101768
-
Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response
-
Sarrazin C., Berg T., Lee J.H., Ruster B., Kronenberger B., Roth W.K., and Zeuzem S. Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response. J. Infect. Dis. 181 (2000) 432-441
-
(2000)
J. Infect. Dis.
, vol.181
, pp. 432-441
-
-
Sarrazin, C.1
Berg, T.2
Lee, J.H.3
Ruster, B.4
Kronenberger, B.5
Roth, W.K.6
Zeuzem, S.7
-
52
-
-
0036839175
-
Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses
-
Sarrazin C., Herrmann E., Bruch K., and Zeuzem S. Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses. J. Virol. 76 (2002) 11079-11090
-
(2002)
J. Virol.
, vol.76
, pp. 11079-11090
-
-
Sarrazin, C.1
Herrmann, E.2
Bruch, K.3
Zeuzem, S.4
-
53
-
-
0034630933
-
Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells
-
Satoh S., Hirota M., Noguchi T., Hijikata M., Handa H., and Shimotohno K. Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells. Virology 270 (2000) 476-487
-
(2000)
Virology
, vol.270
, pp. 476-487
-
-
Satoh, S.1
Hirota, M.2
Noguchi, T.3
Hijikata, M.4
Handa, H.5
Shimotohno, K.6
-
54
-
-
25844523297
-
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
-
Simmonds P., Bukh J., Combet C., Deleage G., Enomoto N., Feinstone S., Halfon P., Inchauspe G., Kuiken C., Maertens G., Mizokami M., Murphy D.G., Okamoto H., Pawlotsky J.M., Penin F., Sablon E., Shin I.T., Stuyver L.J., Thiel H.J., Viazov S., Weiner A.J., and Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42 (2005) 962-973
-
(2005)
Hepatology
, vol.42
, pp. 962-973
-
-
Simmonds, P.1
Bukh, J.2
Combet, C.3
Deleage, G.4
Enomoto, N.5
Feinstone, S.6
Halfon, P.7
Inchauspe, G.8
Kuiken, C.9
Maertens, G.10
Mizokami, M.11
Murphy, D.G.12
Okamoto, H.13
Pawlotsky, J.M.14
Penin, F.15
Sablon, E.16
Shin, I.T.17
Stuyver, L.J.18
Thiel, H.J.19
Viazov, S.20
Weiner, A.J.21
Widell, A.22
more..
-
55
-
-
0027522145
-
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
-
Simmonds P., Holmes E.C., Cha T.A., Chan S.W., McOmish F., Irvine B., Beall E., Yap P.L., Kolberg J., and Urdea M.S. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74 Pt 11 (1993) 2391-2399
-
(1993)
J. Gen. Virol.
, vol.74
, Issue.PART 11
, pp. 2391-2399
-
-
Simmonds, P.1
Holmes, E.C.2
Cha, T.A.3
Chan, S.W.4
McOmish, F.5
Irvine, B.6
Beall, E.7
Yap, P.L.8
Kolberg, J.9
Urdea, M.S.10
-
56
-
-
0034715230
-
Nuclear localization and intramolecular cleavage of N-terminally deleted NS5A protein of hepatitis C virus
-
Song J., Nagano-Fujii M., Wang F., Florese R., Fujita T., Ishido S., and Hotta H. Nuclear localization and intramolecular cleavage of N-terminally deleted NS5A protein of hepatitis C virus. Virus Res. 69 (2000) 109-117
-
(2000)
Virus Res.
, vol.69
, pp. 109-117
-
-
Song, J.1
Nagano-Fujii, M.2
Wang, F.3
Florese, R.4
Fujita, T.5
Ishido, S.6
Hotta, H.7
-
58
-
-
34547781750
-
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0
-
Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol. Biol. Evol. 24 (2007) 1596-1599
-
(2007)
Mol. Biol. Evol.
, vol.24
, pp. 1596-1599
-
-
Tamura, K.1
Dudley, J.2
Nei, M.3
Kumar, S.4
-
59
-
-
0031574072
-
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools
-
Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 (1997) 4876-4882
-
(1997)
Nucleic Acids Res.
, vol.25
, pp. 4876-4882
-
-
Thompson, J.D.1
Gibson, T.J.2
Plewniak, F.3
Jeanmougin, F.4
Higgins, D.G.5
-
60
-
-
2442671740
-
Changes of HCV quasispecies during combination therapy with interferon and ribavirin
-
Ueda E., Enomoto N., Sakamoto N., Hamano K., Sato C., Izumi N., and Watanabe M. Changes of HCV quasispecies during combination therapy with interferon and ribavirin. Hepatol. Res. 29 (2004) 89-96
-
(2004)
Hepatol. Res.
, vol.29
, pp. 89-96
-
-
Ueda, E.1
Enomoto, N.2
Sakamoto, N.3
Hamano, K.4
Sato, C.5
Izumi, N.6
Watanabe, M.7
-
61
-
-
33745451836
-
Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and viral load
-
Ukai K., Ishigami M., Yoshioka K., Kawabe N., Katano Y., Hayashi K., Honda T., Yano M., and Goto H. Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and viral load. World J. Gastroenterol. 12 (2006) 3722-3728
-
(2006)
World J. Gastroenterol.
, vol.12
, pp. 3722-3728
-
-
Ukai, K.1
Ishigami, M.2
Yoshioka, K.3
Kawabe, N.4
Katano, Y.5
Hayashi, K.6
Honda, T.7
Yano, M.8
Goto, H.9
-
62
-
-
34247154928
-
Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy
-
Veillon P., Payan C., Le Guillou-Guillemette H., Gaudy C., and Lunel F. Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy. World J. Gastroenterol. 13 (2007) 1195-1203
-
(2007)
World J. Gastroenterol.
, vol.13
, pp. 1195-1203
-
-
Veillon, P.1
Payan, C.2
Le Guillou-Guillemette, H.3
Gaudy, C.4
Lunel, F.5
-
63
-
-
33846521154
-
Viral determinants of resistance to treatment in patients with hepatitis C
-
Wohnsland A., Hofmann W.P., and Sarrazin C. Viral determinants of resistance to treatment in patients with hepatitis C. Clin. Microbiol. Rev. 20 (2007) 23-38
-
(2007)
Clin. Microbiol. Rev.
, vol.20
, pp. 23-38
-
-
Wohnsland, A.1
Hofmann, W.P.2
Sarrazin, C.3
-
64
-
-
0346121528
-
Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin
-
Yang S.S., Lai M.Y., Chen D.S., Chen G.H., and Kao J.H. Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin. Liver Int. 23 (2003) 426-433
-
(2003)
Liver Int.
, vol.23
, pp. 426-433
-
-
Yang, S.S.1
Lai, M.Y.2
Chen, D.S.3
Chen, G.H.4
Kao, J.H.5
-
65
-
-
33847379731
-
Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4
-
Zekri A.R., El-Din H.M., Bahnassy A.A., Khaled M.M., Omar A., Fouad I., El-Hefnewi M., Thakeb F., and El-Awady M. Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4. Virol. J. 4 (2007) 16
-
(2007)
Virol. J.
, vol.4
, pp. 16
-
-
Zekri, A.R.1
El-Din, H.M.2
Bahnassy, A.A.3
Khaled, M.M.4
Omar, A.5
Fouad, I.6
El-Hefnewi, M.7
Thakeb, F.8
El-Awady, M.9
|